ABEO
Abeona Therapeutics Inc.
There isn't enough reported data to score ABEO yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
ABEO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Under pressure | |
| Unavailable |
ABEO's profitability and cash flow are currently under pressure. There isn't enough data to rate its revenue and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ABEO PE Valuation
ABEO has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ABEO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ABEO's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ABEO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.09 | -192% |
| Q2 2026 | -$1.11 | -271% |
| Q1 2026 | $0.95 | +$2.27 |
| Q4 2025 | $1.01 | +$3.25 |
| Q3 2025 | $1.18 | +$3.82 |
| Q2 2025 | $0.65 | +$3.14 |
| Q1 2025 | -$1.32 | +$1.83 |
| Q4 2024 | -$2.24 | +$0.29 |
ABEO has swung to a loss: it lost $1.09 per share over the past year, after a profit the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over ABEO on earnings quality, reporting a profit while its opponent remains loss making.
ABEO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.4M | +2745% |
| Q2 2023 | $3.5M | +250% |
ABEO's revenue has grown year over year for four quarters in a row: $13M last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | N/A |
| Q2 2026 | -120% | +5578 points |
| Q1 2026 | -264% | N/A |
| Q4 2025 | -423% | N/A |
| Q2 2025 | -5698% | N/A |
| Q2 2023 | -302% | +499 points |
| Q4 2022 | -19024% | N/A |
| Q2 2022 | -801% | N/A |
ABEO's operating margin was −96% last quarter, up 5602 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over ABEO on profitability, with a higher operating margin.
ABEO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.5M | +$15.2M |
| Q2 2026 | -$18M | +$3.7M |
| Q1 2026 | -$20.7M | -$936K |
| Q4 2025 | -$19.1M | -$1.9M |
| Q3 2025 | -$23.7M | -$11.1M |
| Q2 2025 | -$21.7M | -$8.3M |
| Q1 2025 | -$19.8M | -$4.5M |
| Q4 2024 | -$17.2M | -$7.9M |
ABEO has burned cash in almost every quarter: −$66M over the past year, against −$82M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over ABEO on cash generation, producing positive trailing cash flow while its opponent burns cash.
ABEO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +810K shares |
| 1 year | +6.7% | +3.6M shares |
| 3 years | +221% | +39.8M shares |
| 5 years | +1461% | +54.2M shares |
| Available history | +2543% | +55.7M shares |
ABEO has 58M diluted shares, up 6.7% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over ABEO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ABEO Net Leverage
ABEO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ABEO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.4 | Oversold |
| Stochastic | 3.4 | Oversold |
ABEO's weekly RSI is 23 (oversold) and its Stochastic is 3 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ABEO PE vs Healthcare Sector
| Metric | ABEO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ABEO has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
ABEO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.38 | 48% below |
| 20 week MA | $5.50 | 58% below |
| 50 week MA | $5.34 | 57% below |
| 100 week MA | $5.51 | 58% below |
| 200 week MA | $5.09 | 55% below |
ABEO is in a downtrend: it's below all five of its weekly moving averages, and 55% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ABEO on trend strength, trading above more of its moving averages.
ABEO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $85.5 | $43.3 | -49% |
| 2021 | $43.3 | $9.00 | -79% |
| 2022 | $9.00 | $2.51 | -72% |
| 2023 | $2.51 | $5.01 | +100% |
| 2024 | $5.01 | $5.63 | +12% |
| 2025 | $5.63 | $5.45 | -3.2% |
| 2026 YTD | $5.45 | $2.29 | -58% |
ABEO has finished lower in four of the last six years. It's down 58% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over ABEO on returns for 2026, with the stronger performance.